Lilly puts another US$4 million into Infectious Disease research Institute
Eli Lilly is putting more than US$4 million in additional funds into the Infectious Disease Research Institute, the US-based not-for-profit that is a partner in the Lilly TB Drug Discovery Initiative.
The La Jolla Institute for Allergy and Immunology has received a $7.1 million grant from the National Institutes of Health to fund safety and effectiveness testing of an antibody treatment that quickly fights the smallpox virus.